Table 5 Treatments of inclusion subjects
From: Characteristics of Chinese patients with cough in primary care centre
Treatment | Survey 1 | Survey 2 | |||
|---|---|---|---|---|---|
| Â | Â | Cases | Percentage | Cases | Percentage |
Expectorant | 194 | 2.36% | 1 | 0.01% | |
Methylxanthines | 126 | 1.53% | 39 | 0.40% | |
Antihistamines | 197 | 2.40% | 48 | 0.49% | |
Leukotriene modifiers | 104 | 1.27% | 151 | 1.55% | |
SABAS | 43 | 0.52% | 184 | 1.89% | |
LABA | 34 | 0.41% | 53 | 0.55% | |
Anticholinergics | 36 | 0.44% | 2 | 0.02% | |
Combination Drugs | 82 | 1.00% | 1 | 0.01% | |
Chinese traditional medicine | 169 | 2.06% | 14 | 0.14% | |
Inhaled steroids | 180 | 2.19% | 225 | 2.32% | |
Systemic Corticosteroids | 45 | 0.55% | 22 | 0.23% | |
Anti-virus | 6 | 0.07% | 0 | 0.00% | |
| Â | Macrocyclic lactone | 88 | 1.07% | 5 | 0.05% |
| Â | Quinolone | 51 | 0.62% | 0 | 0.00% |
Antibiotics | Cephalosporin | 267 | 3.25% | 243 | 2.50% |
| Â | Benzylpenicillin | 45 | 0.55% | 31 | 0.32% |
| Â | others | 12 | 0.15% | 72 | 0.74% |
Others drugs (unknown) | 414 | 5.04% | 19 | 0.20% | |